Related Experiment Video

Updated: Aug 25, 2026

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease
08:57

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease

Published on: May 22, 2026

Left ventricular diastolic dysfunction: risks, identification, and treatment

Robert E Lamb1, Deborah King

  • 1Medical Affairs, AstraZeneca LP, 1800 Concord Pike, Wilmington, DE 19850, USA. robert.lamb@astrazeneca.com

Progress in Cardiovascular Nursing
|March 16, 2004
PubMed

Insights

Untreated cardiovascular risks like hypertension and diabetes can lead to chronic heart failure. Emerging clinical evidence supports effective treatments for heart failure with preserved systolic function (left ventricular diastolic dysfunction).

Area of Science:

  • Cardiology
  • Heart Failure Research

Background:

  • Cardiovascular diseases (hypertension, diabetes, myocardial infarction) untreated increase chronic heart failure risk.
  • Chronic heart failure with preserved systolic function (left ventricular diastolic dysfunction) lacks extensive clinical trial evidence compared to systolic dysfunction.
  • Treatment for diastolic dysfunction has historically relied on understanding pathophysiology and patient symptoms.

Purpose of the Study:

  • To review risks, identification, and therapeutic rationale for left ventricular diastolic dysfunction.
  • To discuss emerging clinical evidence supporting treatments for diastolic dysfunction.
  • To analyze implications from ongoing and completed trials like CHARM-Preserved and DIG.

Main Methods:

  • Review of existing literature and clinical trial data.
  • Analysis of risk factors and diagnostic approaches for diastolic dysfunction.
  • Evaluation of therapeutic strategies and their supporting evidence.

Main Results:

  • Accumulating clinical evidence from trials like CHARM-Preserved and DIG supports effective treatments for diastolic dysfunction.
  • Ongoing trials are expected to provide further insights into managing this condition.
  • Understanding pathophysiology and patient presentation remains crucial for treatment decisions.

Conclusions:

  • Effective treatments for left ventricular diastolic dysfunction are becoming more defined.
  • Clinical trial results are crucial for evidence-based management of diastolic dysfunction.
  • Further research and ongoing trials will refine therapeutic choices for heart failure with preserved systolic function.

More Related Videos

Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism11:04

Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism

Published on: September 1, 2014

Assessing Intracardiac Vortices with High Frame-Rate Echocardiography-Derived Blood Speckle Imaging in Newborns07:13

Assessing Intracardiac Vortices with High Frame-Rate Echocardiography-Derived Blood Speckle Imaging in Newborns

Published on: December 22, 2023

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...